Prevention by 7-oxo-prostacyclin of the calcium paradox in rat heart: Role of the sarcolemmal (Na,K)-ATPase

  • Attila Ziegelhöffer
  • Tatiana Ravingerová
  • Andrej Džurba
  • Narcisa Tribulová
  • Ján Slezák
  • Albert Breier
  • László Szekeres
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 18)


It is demonstrated a fast and significant depression in the sarcolemmal (Na,K)-ATPase activity that occurs as early as 25 sec after the onset of Ca2+ depletion, and participates in the development of Ca2+-paradox in the rat heart. Pretreatment of the animals with 7-oxo-prostacyclin (PGI2) 24–48 h prior to the experiment prevented fairly the Ca2+-depletion-induced depression in (Na,K)ATPase activity and the accompanying structural and functional damage to the heart and sarcolemma during Ca2+-depletion as well as the development of Ca2+-paradox during the subsequent Ca2+-repletion. Pretreatment with PGI2 was chosen intentionally because previous experiments revealed, that in its late effect the drug is acting via stabilizing the membranes due induction of high activity of (Na,K)-ATPase that has increased affinity to ATP. From results obtained the following may be concluded: If during the phase of Ca2+-deprivation, the capability of heart sarcolemma to maintain sodium extrusion remains preserved, the expected aggravation of Ca2+-overload injury to Ca2+-paradox that would develop during Ca2+-repletion, may be definitely prevented. Sufficiently preserved (Na,K)-ATPase activity, hand in hand with stabilized sarcolemmal structure, may prevent an accumulation of sodium beneath the sarcolemma and consequently also an overexcessive entry of Ca2+ into the myocytes. (Mol Cell Biochem 160/161:257–263, 1996)

Key words

7-oxo-prostacyclin calcium paradox sarcolemmal (Na,K)-ATPase subsarcolemmal sodium subsarcolemmal sodium subsarcolemmal Na/ Ca ratio calcium overload of the heart 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zimmerman ANE, Hülsmann WC: Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211:646–647, 1966PubMedCrossRefGoogle Scholar
  2. 2.
    Chapman RA, Tunstall J: The calcium paradox of the heart. Progr Biophys Mol Biol 50: 67–96, 1987CrossRefGoogle Scholar
  3. 3.
    Ruigrok TJC: Is an increase of intracellular Na+ during Ca2+ depletion essential for the occurrence of the calcium paradox? J Mol Cell Cardiol 23:499–503, 1991CrossRefGoogle Scholar
  4. 4.
    Altschuld RA, Ganote CE, Nayler WG, Pieper HM: What constitutes the calcium paradox? J Mol Cell Cardiol 23: 765–767, 1991PubMedCrossRefGoogle Scholar
  5. 5.
    Tribulová N, Slezák J, Ravingerová T: Influencing of calcium paradox by membrane stabilizing agents: The role of sarcolemma and intercalated disc. J Submicrosc Cytol Patol 25: 267–277, 1993Google Scholar
  6. 6.
    Isenberg G, Wendt-Gallitelli MF: X-ray microprobe analysis of sodium concentration reveals large transverse gradients from the sarcolemma to the centre of voltage clamped guinea-pig ventricular myocytes (Abstract). J Physiol (London) 420: 86P, 1990Google Scholar
  7. 7.
    Carmeliet E: A fuzzy subsarcolemmal space for intracellular Na+ in cardiac cells? Cardiovasc Res 26: 433–442, 1992PubMedCrossRefGoogle Scholar
  8. 8.
    Ravingerová T, Styk J, Trégerová V, Pancza D, Slezák J, Tribulová N, Ziegelhöffer A, Pissarek M, Szekeres L: Protective effect of 7-oxo-prostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox. Basic Res Cardiol 86: 245–253, 1991PubMedCrossRefGoogle Scholar
  9. 9.
    Ravingerová T, Tribulová N, Ziegelhöffer A: The late effect of 7-oxo-prostacyclin protects the rat heart against calcium paradox. Life Sci 53: 1309–1316, 1993PubMedCrossRefGoogle Scholar
  10. 10.
    Chapman RA, Suleiman RS, Rodrigo GC, Tunstall J: The calcium paradox: a role for [Na]., a cellular or tissue basis, a property unique to the Langendorff perfused heart? A bundle of contradictions! J Mol Cell Cardiol 23: 773–777, 1991PubMedCrossRefGoogle Scholar
  11. 11.
    Džurba A, Ziegelhöffer A, Breier A, Vrbjar N, Szekeres L: Increased activity of sarcolemmal (Na+,K+)-ATPase is involved in the late cardioprotective action of 7-oxo-prostacyclin. Cardioscience 2: 7–9, 1991Google Scholar
  12. 12.
    Slezák J, Tribulová N, Schulze W, Ziegelhöffer A, Ravingerová T, Okoličány J, Trégerová V: Differences in transmural distribution of cardiomyocyte injury. Ca-paradox versus postischemic reperfusion phenomenon. Biomed Biochim Acta 48: 102–107, 1989Google Scholar
  13. 13.
    Alto LE, Dhalla NS: Myocardial cation contents during induction of calcium paradox. Am J Physiol 237: 11713–11719, 1979Google Scholar
  14. 14.
    Lamers JMJ, Stinis JT, Ruigrok TJC: Biochemical properties of membranes isolated from calcium-depleted rabbit hearts. Circ Res 54: 217–226, 1984PubMedGoogle Scholar
  15. 15.
    Ziegelöffer A, Ravingerová T, Džurba A, Tribulová T: Changes in sarcolemmal (SL) ATPase activities during calcium depletion are involved in development of calcium paradox (CaP) in rat heart (Abstract). J Mol Cell Cardiol 24: (Supplement 5) S.98, 1992Google Scholar
  16. 16.
    Baker JE., Bullock GR, Hearse DJ: The temperature dependence of the calcium paradox: Functional and morphological correlates of cellular injury. J Mol Cell Cardiol 15: 393–341, 1983PubMedCrossRefGoogle Scholar
  17. 17.
    Brusselen P: Effects of sodium on membrane damage induced by calcium paradox in rat heart (Abstract). J Mol Cell Cardiol 22: 507–522, 1991Google Scholar
  18. 18.
    Piper HM, Siegmund B: The calcium paradox and the oxygen-paradox in heart and isolated cardiomyocytes (Abstract). J Mol Cell Cardiol 23: (Supplement 5) S. 149, 1991CrossRefGoogle Scholar
  19. 19.
    Ruigrok TJC, van Echteid CJA: Pathophysiology of the calcium paradox (Abstract). J Mol Cell Cardiol 24: (Supplement I) S.26, 1992CrossRefGoogle Scholar
  20. 20.
    Severs NJ: The structure and function of cardiac intercellular junctions (Abstract). J Mol Cell Cardiol 23: (Supplement V) S.150, 1991CrossRefGoogle Scholar
  21. 21.
    Ruigrok TJC, van Echteld CJA, The intracellular Na+ concentration prior to Ca2+ repletion has no bearing on the occurrence of the calcium paradox as originally defined. J Mol Cell Cardiol 23: 769–771, 1991PubMedCrossRefGoogle Scholar
  22. 22.
    Ziegelhöffer A, Grünermel J, Džurba A, Procházka J, Kolář F, Vrbjar N, Pelouch V, Oštádal B, Szekeres L: Sarcolemmal cation transport systems in rat hearts acclimatized to high altitude hypoxia. Influence of 7-oxo-prostacyclin. In: B. Oštádal and N.S. Dhalla (eds). Heart Function in Health and Disease. Kluwer Academic Publishers, Boston, 1993, pp 219–228CrossRefGoogle Scholar
  23. 23.
    Ziegelhöffer A, Ravingerová T, Džurba A, Slezák J, Tribulová N, Szekeres L: High Na/K-ATPase activity induced by pretreatment with 7-oxo prostacyclin (PGI2) is involved in prevention of Ca-paradox (CaP) in the rat heart (Abstract). J Mol Cell Cardiol 23: (Supplement V)S.161, 1991Google Scholar
  24. 24.
    Chapman RA: A rise in intracellular sodium would seem to predispose the heart to the calcium paradox. J. Moll Cell Cardiol 22: 503–507, 1990CrossRefGoogle Scholar
  25. 25.
    Slezák J, Tribulová N, Ravingerová T, Ziegelhöffer A, De Nollin S, Ruigrok TJC: The effect of lidocaine on concentration and localization of Ca2+ in Ca2+-depleted and Ca2+-repleted hearts (Abstract). J Mol Cell Cardiol 23: (Supplement V) S. 161, 1991Google Scholar
  26. 26.
    van Echteld CJA, Kirkels JH, Eijgelshoven HMJ, van der Meer P, Ruigrok TJC: Intracellular sodium during ischemia and calcium free perfusion: A 23Na NMR study. J Mol Cell Cardiol 23: 297–308, 1991PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Attila Ziegelhöffer
    • 1
  • Tatiana Ravingerová
    • 1
  • Andrej Džurba
    • 1
  • Narcisa Tribulová
    • 1
  • Ján Slezák
    • 1
  • Albert Breier
    • 2
  • László Szekeres
    • 3
  1. 1.Institute for Heart ResearchSlovak Academy of SciencesBratislavaSlovak Republic
  2. 2.Institute of Molecular Physiology and GeneticsBratislavaSlovak Republic
  3. 3.Institute of PharmacologyAlbert Szent-Györgyi Medical UniversitySzegedHungary

Personalised recommendations